1. Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors: Time for Clinical Outcome Prediction and Biosimilar vs Biologic Originator Performance

   • Matteo Colina
   • Micheline Khodeir
   • Gabriele Campana

   Original Research Article Open access 31 January 2024 Pages: 141 - 148

   

2. Cost-Effectiveness Analysis of Camrelizumab Plus Rivoceranib Versus Sorafenib as a First-Line Therapy for Unresectable Hepatocellular Carcinoma in the Chinese Health Care System

   • Wenwang Lang
   • Lian Deng
   • Ming Ouyang

   Original Research Article 01 February 2024 Pages: 149 - 162

   

3. Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia

   • Shanshan Nie
   • Yuhang Zhao
   • Guoping Yang

   Original Research Article 07 February 2024 Pages: 163 - 174

   

4. Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical Center

   • Felicia Y. Wang
   • Kevin C. McLaughlin
   • Robert E. Dannemiller

   Original Research Article 16 February 2024 Pages: 175 - 181

   

5. Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C)

   • Christopher F. Bell
   • Priyanka Bobbili
   • the N3C consortium

   Original Research Article Open access 20 February 2024 Pages: 183 - 198

   

6. Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database

   • Xiongwen Yang
   • Bo Yang
   • Chengxiao Fu

   Original Research Article 20 February 2024 Pages: 199 - 207

   

7. Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model

   • Ryan Thaliffdeen
   • Anthony Yu
   • Karen Rascati

   Original Research Article 21 February 2024 Pages: 209 - 217

   

8. Safety and Efficacy of Biologic Medications and Janus Kinase Inhibitors in Patients with Down Syndrome: A Retrospective Cohort Study

   • Linnea Westerkam
   • Lauren Pearson
   • Christopher Sayed

   Research Letter 19 February 2024 Pages: 219 - 222